Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AMGN | VRTX | BMY | GILD |
| Company | Intra-Cellular Ther | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 88.00 | 295.21 | 495.62 | 58.20 | 91.65 |
| High | 89.33 | 295.21 | 496.33 | 58.20 | 91.65 |
| Low | 87.40 | 295.21 | 483.55 | 58.20 | 91.65 |
| Last | 87.63 | 295.21 | 483.96 | 58.20 | 91.65 |
| Change | -0.59 | -0.72 | -10.65 | -0.30 | -0.46 |
| % Change | -0.67% | -0.24% | -2.15% | -0.51% | -0.50% |
| Volume | 616,300 | 1,562 | 1,231,500 | 222,693 | 10,500 |
| 20-Day Average Volume | 726,815 | 2,246,393 | 1,180,065 | 10,491,350 | 6,753,670 |
| Previous Close | 88.22 | 295.93 | 494.61 | 58.50 | 92.11 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 83.58 | 314.52 | 484.02 | 55.01 | 90.85 |
| 20-Day Raw Stochastic | 68.86% | 8.03% | 36.69% | 68.93% | 45.49% |
| 20-Day Relative Strength | 63.88% | 33.33% | 50.71% | 63.20% | 58.59% |
| Weighted Alpha | +53.48 | +4.76 | +31.67 | +24.26 | +30.18 |
| Today's Opinion | 100% Buy | 40% Sell | 72% Buy | 100% Buy | 96% Buy |
| Previous Opinion | 100% Buy | 40% Sell | 88% Buy | 100% Buy | 96% Buy |
| Last Month's Opinion | 88% Buy | 24% Buy | 56% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.18% since 11/07/24 | -9.24% since 11/08/24 | -3.68% since 11/07/24 | +7.50% since 11/08/24 | -5.09% since 11/08/24 |
| Low | 87.40 on 11/14/24 | 292.33 on 11/14/24 | 483.55 on 11/14/24 | 57.84 on 11/13/24 | 91.29 on 11/14/24 |
| High | 93.45 on 11/11/24 | 327.58 on 11/11/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | +18.68% since 10/14/24 | -9.19% since 10/15/24 | -0.18% since 10/14/24 | +10.31% since 10/15/24 | +6.79% since 10/15/24 |
| Low | 73.82 on 10/15/24 | 292.33 on 11/14/24 | 463.14 on 11/01/24 | 51.81 on 10/28/24 | 85.60 on 10/22/24 |
| High | 93.45 on 11/11/24 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +15.88% since 08/14/24 | -9.28% since 08/15/24 | +2.66% since 08/14/24 | +18.51% since 08/15/24 | +23.28% since 08/15/24 |
| Low | 70.90 on 10/07/24 | 292.33 on 11/14/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.89 on 08/16/24 |
| High | 93.45 on 11/11/24 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +33.36% since 05/14/24 | -7.47% since 05/15/24 | +12.92% since 05/14/24 | +30.64% since 05/15/24 | +36.77% since 05/15/24 |
| Low | 64.09 on 05/20/24 | 292.33 on 11/14/24 | 428.62 on 05/15/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 93.45 on 11/11/24 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,290,269 | 159,072,144 | 124,633,728 | 118,648,352 | 114,793,560 |
| Shares Outstanding, K | 106,017 | 537,533 | 257,529 | 2,028,177 | 1,246,266 |
| Annual Sales | 464,370,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -139,670,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 175,380,000 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -26,320,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.97 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.25 on 10/30/24 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 10/30/24 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.68 | 0.00 | 49.92 | 20.91 |